PERKASIE, Pa.--(BUSINESS WIRE)--Secant Medical, Inc. will discuss how biomedical textiles enhance the function of medical devices, from heart valves and hernia meshes to sutures and stent-grafts, at the BIOMEDevice Exhibition and Conference in Boston, MA on April 10-11, 2013.
Biomedical textile engineering and biomaterials science are addressing the need for flexible, versatile and low-profile medical devices. Secant Medical's engineers will be educating attendees about how the combination of biomaterials research, analysis and engineering can enable device design at its booth (#763) during the BIOMEDevice event.
“Secant Medical is continuing to expand its capabilities and services with a focus on evolving biomaterial technologies to fulfill unmet needs in the industry,” said Stephanie Lietz, development manager at Secant Medical. “BIOMEDevice is a great forum to chat with device developers and understand how materials and geometry can enhance design.”
BIOMEDevice Expo brings together hundreds of world-class suppliers, exhibiting the latest medical-grade materials, assembly components, design and engineering support, as well as a full range of services for every phase of the medical product development process ranging from initial start-up and R&D through end-product marketing.
About Secant Medical: Secant Medical® designs and manufactures biomedical textiles and other structures for medical devices. Employing medical fabric engineering technologies, we blend polymeric, metallic and resorbable biomaterials to create custom, high-performance structures that are used in the cardiovascular, general surgery, neurovascular, orthopedic and regenerative medicine fields. Built on a 70-year history, we’re committed to the future of biomaterials and their role in the healing process and are actively engaged in research partnerships to advance next-generation biomaterial development. Secant Medical is a business unit of Fenner PLC, a worldwide leader in reinforced polymer engineering headquartered in Yorkshire, England. For more information, contact Maria Fontanazza at 215-257-8680 x2192 or maria.fontanazza@secantmedical.com; or visit www.secantmedical.com/release-entry.php.